Cite
HARVARD Citation
El-Khoueiry, A. et al. (n.d.). 411 Novel intratumoral agent, INT230–6 induces cancer cell death, increases tumor infiltrates and results in durable benefit alone or in combination with pembrolizumab in refractory patients. Journal for immunotherapy of cancer. p. A250. [Online].